azenta (nasdaq: azta) is a leading provider of life sciences solutions worldwide, enabling impactful breakthroughs and therapies to market faster.   azenta provides a full suite of reliable cold-chain sample management solutions and genomic services across

Azenta, Inc.

Sold all AZTA

This member connected a brokerage account and is sharing trades and portfolio performance with the community. 

Public Portfolio

Arthur Knesbach

Sold <1% of AZTA

Sold 50% of AZTA

Bought 100% more AZTA

New position in AZTA

Steven

Taylor Duran

Bought to close all AZTA

Baljinder

Sold short AZTA

Sold $1k-$15k AZTA

This profile creates auto-generated trade alerts based on public disclosures.

Congressional Investor

Rep. Josh Gottheimer

Sold 100% of AZTA